SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-11-001031
Filing Date
2011-04-28
Accepted
2011-04-28 12:23:11
Documents
17
Period of Report
2011-06-10
Effectiveness Date
2011-04-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT regeneron_def14a.htm DEF 14A 1119966
2 regeneron_def14a1x1x1.jpg GRAPHIC 12060
3 regeneron_def14a1x1x2.jpg GRAPHIC 5782
4 murrayx1x1.jpg GRAPHIC 8543
5 regeneron_def14a1x7x1.jpg GRAPHIC 8835
6 regeneron_def14a1x8x1.jpg GRAPHIC 8656
7 regeneron_def14a1x8x3.jpg GRAPHIC 7962
8 regeneron_def14a1x8x2.jpg GRAPHIC 9130
9 regeneron_def14a1x9x1.jpg GRAPHIC 8991
10 regeneron_def14a1x9x2.jpg GRAPHIC 9113
11 regeneron_def14a1x10x1.jpg GRAPHIC 8577
12 regeneron_def14a1x10x2.jpg GRAPHIC 8873
13 regeneron_def14a1x10x3.jpg GRAPHIC 7943
14 regeneron_def14a1x11x1.jpg GRAPHIC 9425
15 regeneron_def14a1x11x2.jpg GRAPHIC 8965
16 proxycardx1x1.jpg GRAPHIC 2976
17 proxycardx2x1.jpg GRAPHIC 3088
  Complete submission text file 0001206774-11-001031.txt   1300785
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19034 | Film No.: 11786697
SIC: 2834 Pharmaceutical Preparations